37.15 - 38.24
22.75 - 39.30
1.11M / 91.9K (Avg.)
12.71 | 2.99
Analyze analyst forecasts for the company and compare them with competitors.
219.67B
The estimated revenue has increased from the previous period.
100.23B
The estimated EBITDA has increased from the previous period.
8.99
The estimated EPS has decreased from the previous period.
1.80B
The estimated net income has decreased from the previous period.
53.27B
The estimated EBIT has increased from the previous period.
13.46B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
58.92B
Revenue has increased from the previous period.
93.09%
Revenue growth rate is unchanged from the previous period.
26.88B
EBITDA has increased from the previous period.
45.63%
EBITDA margin is unchanged from the previous period.
14.29B
EBIT has increased from the previous period.
24.25%
EBIT margin is unchanged from the previous period.
12.59B
Depreciation has increased from the previous period.
9.30B
Total cash has increased from the previous period.
15.78%
Cash percentage is unchanged from the previous period.
9.62B
Receivables have increased from the previous period.
16.33%
Receivables percentage is unchanged from the previous period.
-3.47B
Inventories have decreased from the previous period.
-5.88%
Inventory percentage is unchanged from the previous period.
9.45B
Accounts payable has increased from the previous period.
16.04%
Payables percentage is unchanged from the previous period.
-34.43B
Capital expenditure has increased from the previous period.
-58.44%
CapEx percentage is unchanged from the previous period.
13.88%
WACC is unchanged from the previous period.
18.00%
Cost of equity is unchanged from the previous period.
7.81%
Cost of debt is unchanged from the previous period.
2.84
Beta is unchanged from the previous period.
199.90M
Diluted shares outstanding is unchanged from the previous period.
3.07B
Total debt is unchanged from the previous period.
6.21B
Total equity is unchanged from the previous period.
9.28B
Total capital is unchanged from the previous period.
33.09%
Debt weighting is unchanged from the previous period.
66.91%
Equity weighting is unchanged from the previous period.
10.15B
EBIAT has increased from the previous period.
-10.10B
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-167.53B
Terminal value is unchanged from the previous period.
-110.69B
Enterprise value is unchanged from the previous period.
3.09B
Net debt is unchanged from the previous period.
-113.78B
Equity value is unchanged from the previous period.
-569.17
Equity value per share is unchanged from the previous period.
